Aequs board to weigh promoter warrants on Sep 25, 2026

What Aequs has put on the agenda

Aequs Ltd has scheduled a meeting of its board of directors on September 25, 2026 to consider a preferential issue of warrants that are convertible into equity shares. The warrants are proposed to be issued to the company’s promoter and may be offered in one or more tranches. Alongside the warrant proposal, the board will also consider convening an extraordinary general meeting (EGM) to seek shareholder approval for the issuance.

The disclosure was filed with the exchanges as a board meeting intimation for a preferential issue of warrants convertible into equity shares and for calling an EGM. The filing references compliance under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has stated that execution of the proposal will require shareholder consent and other statutory approvals.

Preferential warrant issue: what is being considered

The proposal before the board is a preferential issue of warrants convertible into equity shares of the company. Preferential issues typically involve allotment to a specific investor class, in this case the promoter, rather than a broad public issuance. Because warrants convert into equity, they can increase the share capital when conversion takes place, depending on final terms and conversion.

In its exchange communication, Aequs indicated that the issuance would be subject to regulatory approvals under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as well as requirements under the Companies Act, 2013. The company also indicated that shareholder approval will be sought through an EGM.

Approvals and process highlighted by the company

Aequs has explicitly linked the intimation to Regulation 29 of the SEBI LODR framework, which governs disclosure around board meetings and material matters. The company has also noted that the proposal requires shareholder approval and approvals from statutory authorities before it can be executed.

The exchange filing was signed by Ravi Mallikarjun Hugar, Company Secretary and Compliance Officer. The disclosure was addressed to the National Stock Exchange of India Limited and BSE Limited. The BSE scrip identifier referenced in the disclosure is Aequs Ltd - 544634.

Stock price check on September 25

On September 25, 2026 at 9:23 AM (IST), Aequs was quoted at ₹247.52, up ₹4.73 (1.95%). The stock opened at ₹244 compared with a previous close of ₹243. During the morning session snapshot provided, the intraday high was ₹250 and the intraday low was ₹244.

Separately, the data also notes that as of September 24, 2026 at 15:59, Aequs Ltd was trading at ₹242.79. These are point-in-time observations and reflect how the stock traded around the board meeting date.

Shareholding movement across recent quarters

The shareholding table provided shows the promoter holding trending lower from September 2025 to December 2025, before stabilising around 59% in March and June 2026. FII and DII holdings appear from December 2025 onward in the table. Public or retail holding is also shown increasing between December 2025 and June 2026.

The number of shareholders in the table rises sharply in March 2026 and increases further by June 2026. While the table does not explain the reason for this increase, it provides a useful view of how the shareholder base changed across the periods listed.

Promoter-linked pledge disclosure also in focus

The broader information set also references a pledge by Melligeri Private Family Foundation. It states that the entity pledged 100% of its 10,05,13,070 shares, representing 14.99% of Aequs Limited. The pledge is described as securing a ₹200 crore finance facility from 360 One Prime Ltd for investment purposes.

The same set of highlights notes a security cover ratio of 11.50:1, with share value at ₹2,300.74 crore against the loan amount. The text does not connect this pledge directly to the proposed preferential warrant issue, but it is presented as a separate, relevant promoter-linked disclosure.

Why shareholder approval matters in this case

Aequs has said it intends to call an EGM to seek shareholder approval for the preferential issuance. Preferential warrants that can convert into equity are often examined by investors for potential dilution effects if conversion takes place, and for the pricing and terms once disclosed. The company’s filing, as presented, is an initiation step that signals board-level consideration and the need for shareholder consent before implementation.

The information set also mentions that all 12 resolutions at Aequs Ltd’s 26th AGM were passed by shareholders, and that promoters voted unanimously in favour of all eligible resolutions with 99.98% participation. While that AGM vote relates to a different set of resolutions, it provides context on recent shareholder voting outcomes.

Contacts and investor grievance information shared

The data includes contact points for investor queries and grievance redressal. It lists Mr. Ravi Hugar as Company Secretary and Compliance Officer, with an investor relations email address provided. It also includes a registrar-related contact line and email.

These details are typically relevant for shareholders who want formal clarification on corporate actions, meeting notices, or procedural steps once the EGM notice and explanatory statement are issued.

What to watch next

The immediate next milestone is the outcome of the September 25, 2026 board meeting, including whether the board approves the preferential warrant issue proposal and the EGM convening. After that, the key step will be shareholder voting at the EGM, followed by any regulatory and statutory clearances referenced by the company.

For investors tracking Aequs, the core variables will be the final terms that are eventually disclosed, the timeline for any tranches, and the formal documentation around shareholder approval and regulatory compliance under SEBI ICDR and the Companies Act.